Bailey Gleason Fitzgerald
@baileyfitz
ID: 16214079
10-09-2008 00:36:41
39 Tweet
170 Followers
219 Following
PGY-3 Kayle Shapero taking us through the decade's Top 10 advancements in #cardiology: #CAC scores, #SGLT2 inhibitors, hyperTG, DOAC's, tafamadis, #Entresto, #PCSK9 inhibitors, #GOREDFORWOMEN, and precision medicine, and red meat controversy.
Social media for physicians: benefits, challenges, and opportunities ahead by Leila Haghighat Yale Internal Medicine Chiefs #yalemgr #some #SoMeDocs Yale School of Medicine
Wonderful Yale Internal Medicine grand rounds on use of social media by physicians. Great job Leilah! Yale Internal Medicine Chiefs
We can't contain our excitement for our fellowship APD Deborah Doroshow being awarded the prestigious ASCO #ConquerCancer Career Development Grant! 💫 Grateful to have such role models in our faculty. Conquer Cancer, the ASCO Foundation The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai Mount Sinai Health System
Warmest of welcomes to our new first year fellows! Looking forward to working and learning with you all as we start another great year Icahn School of Medicine at Mount Sinai!
1/ AmericanJournalofHematology during National Organization for Rare Disorders (NORD) month. Rituximab-splenectomy-TPO or splenectomy-rituximab-TPO is cost-effective in 100% of treatment iterations in our patients with chronic ITP. Findings despite base model design heavily favoring TPO.
Today at ASCO, Drs. Melanie Wain Kier, Edgar Gonzalez-Kozlova, Rima Patel, and Bailey Gleason Fitzgerald, shared their latest oncology research during their poster sessions. #ASCO22 The Tisch Cancer Institute
.Bailey Gleason Fitzgerald presented today at stephane gragnani: A phase 1b/2 trial of dupilumab given in conjunction with PD-(L)1 blockade in the treatment of relapsed/refractory metastatic NSCLC. meetings.asco.org/abstracts-pres… Mount Sinai Health System Icahn School of Medicine at Mount Sinai
Devika Das, MD, MSHQS Stephen V Liu, MD Bailey Gleason Fitzgerald and I are opening a study at Mount Sinai Thoracic Oncology of 1L pembro for pts with PS 2-3 with primary endpoint QOL - hoping to start enrolling by Fall!
What a great workshop, thank you Society for Translational Oncology! Great to meet so many amazing young oncologists, learn from leaders in translational research and catch up with old friends and colleagues Bailey Gleason Fitzgerald, Dr. David Schoenfeld Yale Hematology Oncology Fellows Yale Internal Medicine
End-of-summer fellows & faculty picnic in Central Park replete with food, games, sun and camaraderie! 👏🏼 to our wellness committee - @AzziJacques Rima Patel Sridevi Rajeeve, MD Bailey Gleason Fitzgerald @orrinpail @RSJSheppard Wang Xuejun The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai
🚨On behalf of my amazing co-authors, I'm super excited to share our findings on safety/efficacy of #ICI for #NSCLC among people living w/ #HIV as an oral presentation #SITC2022 (Thurs. @ 7pm). Effort co-led w/🌟Amin Nassar, MD Elio Adib & best mentors Rafeh Naqash, MD Guru P. Sonpavde, MD!
Tonight at 7:30pm on Yale Cancer Answers, join us to learn about the field of classical #hematology and current research initiatives into rare blood disorders with George Goshua, MD MSc. Listen live on Connecticut Public or iTunes. Yale Hematology Oncology Fellows YaleHematology Smilow Cancer Hospital Yale School of Medicine
We are delighted to present our newest class of incoming hematology and oncology fellows The Tisch Cancer Institute Mount Sinai Health System! In no particular order....